首页> 外国专利> BACTERIAL NITROREDUCTASE TO REDUCE CB 1954 AND ANALOGUE IT INTO A CYTOTOXIC FORM

BACTERIAL NITROREDUCTASE TO REDUCE CB 1954 AND ANALOGUE IT INTO A CYTOTOXIC FORM

机译:细菌硝基还原酶可降低CB 1954的含量并将其模拟为细胞毒性形式

摘要

The invention provides a nitroreductase, obtainable from a bacterium having the following characteristics as exemplified by examples isolated from Escherichia coli B and Bacillus amyloliquifaciens: 1. It is a flavoprotein having a molecular weight in the range 20-60 Kilodaltons; 2. It requires either NADH or NAD(P)H or analogues thereof as a cofactor; 3. It has a Km for NADH or NAD(P)H in the range 1-1000M; and 4. It is capable of reducing either or both nitro groups of CB 1954 and analogues thereof to a cytotoxic form e.g. the hydroxylamine. The sequence of one such nitroreductase is shown in Seq. ID No.1. The nitroreductase may be conjugated to a tumor targeting agent such as a monoclonal antibody and used to convert prodrugs into active antitumour agents. Such prodrugs and drugs are also provided.
机译:本发明提供了一种可从具有以下特征的细菌获得的硝基还原酶,该细菌具有从大肠杆菌B和解淀粉芽孢杆菌分离的实施例所举例说明的:1.一种黄素蛋白,其分子量为20-60千道尔顿; 2.它需要NADH或NAD(P)H或其类似物作为辅因子; 3.对于NADH或NAD(P)H,其Km为1-100 0 M; 4.能够将CB 1954及其类似物的硝基中的一个或两个还原成细胞毒性形式,例如CB 1954。羟胺。一种这样的硝基还原酶的序列在Seq.ID.No.1中示出。编号1。所述硝基还原酶可以缀合至肿瘤靶向剂,例如单克隆抗体,并用于将前药转化为活性抗肿瘤剂。还提供了此类前药和药物。

著录项

  • 公开/公告号DE69233669T2

    专利类型

  • 公开/公告日2007-10-25

    原文格式PDF

  • 申请/专利权人 CANCER RESEARCH TECHNOLOGY LTD.;

    申请/专利号DE19926033669T

  • 发明设计人

    申请日1992-10-23

  • 分类号C12N15/53;C12N9/02;C12P21/08;C12P7/10;C07K7/06;C07D487/14;C07D203/14;C07C271/18;

  • 国家 DE

  • 入库时间 2022-08-21 20:27:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号